In another post he also mentions that all the vaccines contain Polyethylene Glycol and links a study from 2018 on "Physician Awareness of Immune Responses to Polyethylene Glycol-Drug Conjugates". Archive.All I'm saying is if you picture the Spike proteins like a drug, they're half-life is 10 minutes. As in, in 10 minutes 50% of them will be degraded by proteases in the blood. Now mind, it takes 1 minute for blood to fully pump around the body.
My argument is that they're not going to stick around in the body for months or for years. That being said, is it possible for the Spike proteins to stick to the vasculature and provoke an inflammatory immune response? And since the immune response of young people would be stronger? Yes. An immune response can stick around longer than the protein itself, so it could hyper activate, attacking vasculature. It wouldn't be the Spike protein itself responsible, but the excessive immune response. You also have to understand, even if the Spike protein is gone, an immune response doesn't just stop. There's a ramp up time. So it ramps up in two days, excessively attacks the vasculature and symptoms appear two days later. Despite most of the mRNA and Spike sticking around at the injection site, some makes it into the plasma. You also have to remember, its not the Spike protein doing the damage, its our immune response to it.
In all honesty, we can't know if the reaction [in reference to Bad Take Crucifier's partner's ongoing reaction to the Moderna vaccine] was from the mRNA itself, the Spike protein or even one of the other constituents of the vaccine. The COVID vaccine contains Polyethylene Glycol. It sounds bad, but it is literally in everything. It could be that they were sensitized to that and is having an immune response to that.
Ultimately his major concern--much the like aforementioned Dr. Byram Bridle--is with regards to a lack of sufficient safety testing, lack of transparency in scientific study, the politicization of bias regarding the vaccines and the widespread notice of side effects (blood clots, myocarditis, etc.) which may be caused by the Spike protein in the vaccine or other elements of it, among other subjects.Western Journal said:But Malone’s wariness coincides with the development of a “traditional” vaccine introduced by the U.S.-based company Novavax that’s now being labeled the “Coronavax.”
According to TrialSite News, this traditional vaccine “demonstrated 100% protection against moderate and severe disease” and “90.4% overall efficacy,” keeping this “Coronavax” competitive with mRNA-based vaccines and superior to the Adenovirus-based Johnson & Johnson vaccine.
ARRs tend to be ignored [in reports] because they give a much less impressive effect size than RRRs: 1·3% for the AstraZeneca–Oxford, 1·2% for the Moderna–NIH, 1·2% for the J&J, 0·93% for the Gamaleya, and 0·84% for the Pfizer–BioNTech vaccines. ARR is also used to derive an estimate of vaccine effectiveness, which is the number needed to vaccinate (NNV) to prevent one more case of COVID-19 as 1/ARR.
There are many lessons to learn from the way studies are conducted and results are presented. With the use of only RRRs, and omitting ARRs, reporting bias is introduced, which affects the interpretation of vaccine efficacy.10 When communicating about vaccine efficacy, especially for public health decisions such as choosing the type of vaccines to purchase and deploy, having a full picture of what the data actually show is important, and ensuring comparisons are based on the combined evidence that puts vaccine trial results in context and not just looking at one summary measure, is also important. Such decisions should be properly informed by detailed understanding of study results, requiring access to full datasets and independent scrutiny and analyses.
Enclosed at the bottom in the OP is a PDF of the publication. Credit to @knobslobbinUnfortunately, comparing vaccines on the basis of currently available trial (interim) data is made even more difficult by disparate study protocols, including primary endpoints (such as what is considered a COVID-19 case, and when is this assessed), types of placebo, study populations, background risks of COVID-19 during the study, duration of exposure, and different definitions of populations for analyses both within and between studies, as well as definitions of endpoints and statistical methods for efficacy. Importantly, we are left with the unanswered question as to whether a vaccine with a given efficacy in the study population will have the same efficacy in another population with different levels of background risk of COVID-19.
So there's a little media/twitter tard fight going on in Canada RN. The country's highest authority on vaccines stated they do not recommend the Astra Zeneca vaccine to young people under 30, especially ones who don't go out much and live in provinces like those in Atlantic Canada who aren't as hard hit because the risk of the clots is actually higher than dying of COVID in that age group.
This caused some I FUCKING LOVE SCIENCE people to tard rage on twitter and call our country's vaccine authority "anti-vaxers" who are "spreading disinformation". [...]
EXCERPT: Of the three "variants of concern" recognized by the World Health Organization and the CDC, studies have shown that the mRNA vaccines created by Pfizer/BioNTech and Moderna, as well as the Novavax vaccine, remain highly effective against the B.1.1.7 variant, which was first recognized in the United Kingdom.
The mRNA vaccines are 4- to 7-fold less effective against the P.1 variant, which was first discovered in Brazil, but they still appear to be within an important "cushion of protection," particularly after two doses, and should prevent disease, according to Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
The B.1.351 variant is more troublesome. Studies have shown that the AstraZeneca vaccine was 86 times less effective against this variant, which was first detected in South Africa. The mRNA vaccines are 6- to 8-fold less effective against this variant, suggesting a significant waning of protection. In clinical trials in South Africa, the Johnson & Johnson vaccine also was less effective where this variant was surging.
Above Article said:“It is very rare for a blanket immunity law to be passed,” said Rogge Dunn, a Dallas labor and employment attorney. “Pharmaceutical companies typically aren’t offered much liability protection under the law.“
You also can’t sue the Food and Drug Administration for authorizing a vaccine for emergency use, nor can you hold your employer accountable if they mandate inoculation as a condition of employment.
...
In February, Health and Human Services Secretary Alex Azar invoked the Public Readiness and Emergency Preparedness Act. The 2005 law empowers the HHS secretary to provide legal protection to companies making or distributing critical medical supplies, such as vaccines and treatments, unless there’s “willful misconduct” by the company. The protection lasts until 2024. That means that for the next four years, these companies “cannot be sued for money damages in court” over injuries related to the administration or use of products to treat or protect against Covid.
“When the government said, ‘We want you to develop this four or five times faster than you normally do,’ most likely the manufacturers said to the government, ‘We want you, the government, to protect us from multimillion-dollar lawsuits,’” said Dunn.
“The government doesn’t want people suing the companies making the Covid vaccine. Because then, the manufacturers would probably charge the government a higher price per person per dose,” Dunn explained.
Remember, vaccine manufacturers aren’t the ones approving their product for mass distribution. That is the job of the FDA.
Which begs the question, can you sue the U.S. government if you have an extraordinarily bad reaction to a vaccine?
“You can’t sue the FDA for approving or disapproving a drug,” said Dorit Reiss, a professor at the University of California Hastings College of Law. “That’s part of its sovereign immunity.”
_.
Wow, expressing this as it actually is sounds super fucking sketchy, doesn't it?
Credit to @Lawrence of AlgeriaAbove Article said:The US-based company sent a team of its doctors into the Nigerian slum city of Kano in the midst of an appaling meningitis epidemic to perform what it calls a "humanitarian mission". However the accusers claim it was an unlicensed medical trial on critically-ill children.
A team of Pfizer doctors reached the Nigerian camp just as the outbreak, which killed at least 11,000 people, was peaking. They set themselves up within metres of a medical station run by the aid group Médecins Sans Frontières, which was dispensing proven treatments to ease the epidemic.
From the crowd that had gathered at the Kano Infectious Diseases Hospital, 200 sick children were picked. Half were given doses of the experimental Pfizer drug called Trovan and the others were treated with a proven antibiotic from a rival company.
Eleven of the children died and many more, it is alleged, later suffered serious side-effects ranging from organ failure to brain damage. But with meningitis, cholera and measles still raging and crowds still queueing at the fence of the camp, the Pfizer team packed up after two weeks and left.
That would probably have been an end to the story if it weren't for Pfizer employee, Juan Walterspiel. About 18 months after the medical trial he wrote a letter to the then chief executive of the company, William Steere, saying that the trial had "violated ethical rules". Mr Walterspiel was fired a day later for reasons "unrelated" to the letter, insists Pfizer.
...
At stake at one point last year was more than $8bn in punitive damages being sought in a string of cases, as well as potential jail terms in Nigeria for several Pfizer staff.
...
Trovan never became the blockbuster that Pfizer had hoped for and it is no longer in production. The EU has banned the drug and it has been withdrawn from sale in the US.
_.